Diabetes Clinical Trials in Pennsylvania

Showing 321-340 of 572 trials

Program Reinforcement Impacts Self Management (PRISM)

NCT01343056

Patients who receive DSME (Diabetes Self Management Education) will be enrolled in a 4 arm, randomized study with each group receiving a different method of follow up. The 4 arms will be evaluated based on clinical indicators, goal achievement and patient satisfaction.

Diabetes Mellitus

University of Pittsburgh141 participantsStarted Apr 2011

Hershey, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 341 miles

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

NCT01606007

The purpose of this study is to learn if a combination of BMS-477118 (Saxagliptin) and BMS -512148 (Dapagliflozin) added to Metformin can improve (decrease) Glycosylated Hemoglobin (Hemoglobin A1c) in patients with type 2 diabetes after 24 weeks of treatment. The safety of this treatment will also be studied.

Type 2 Diabetes

AstraZeneca1,282 participantsStarted Jul 2012

Birmingham, Alabama, United States • Homewood, Alabama, United States • Muscle Shoals, Alabama, United States +136 more locations

Program Reinforcement Impacts Self Management (PRISM)

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Diabetes Trials in Other Cities

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Study In People With Type 2 Diabetes

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

Thiazolidinedione Intervention With Vitamin D Evaluation

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes

Other Conditions in Pennsylvania